<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; pfizerline</title>
	<atom:link href="http://www.tapanray.in/tag/pfizerline/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Declining MR Access to Doctors Prompts Increased Digital Engagement</title>
		<link>http://www.tapanray.in/declining-mr-access-to-doctors-prompts-increased-digital-engagement/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=declining-mr-access-to-doctors-prompts-increased-digital-engagement</link>
		<comments>http://www.tapanray.in/declining-mr-access-to-doctors-prompts-increased-digital-engagement/#comments</comments>
		<pubDate>Sun, 02 Oct 2016 23:58:07 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Aceess]]></category>
		<category><![CDATA[Act]]></category>
		<category><![CDATA[channels]]></category>
		<category><![CDATA[Declining]]></category>
		<category><![CDATA[Department]]></category>
		<category><![CDATA[digital]]></category>
		<category><![CDATA[doctors]]></category>
		<category><![CDATA[DoP]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[joint]]></category>
		<category><![CDATA[mandatory]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[of pharmaceuticals]]></category>
		<category><![CDATA[Pant]]></category>
		<category><![CDATA[Payment]]></category>
		<category><![CDATA[pfizerline]]></category>
		<category><![CDATA[Physician]]></category>
		<category><![CDATA[platforms]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Representatives]]></category>
		<category><![CDATA[sales]]></category>
		<category><![CDATA[secretary]]></category>
		<category><![CDATA[Sudhanshu]]></category>
		<category><![CDATA[Sunshine]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[UCPMP]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=7850</guid>
		<description><![CDATA[The trigger point for a disruptive change in the pharma marketing playbook now seems to be not just on the horizon, but could soon move to a countdown stage, in India. On Friday, September 16, 2016, at a seminar on &#8230; <a href="http://www.tapanray.in/declining-mr-access-to-doctors-prompts-increased-digital-engagement/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/declining-mr-access-to-doctors-prompts-increased-digital-engagement/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>‘e-detailing’: The Future of Pharmaceutical Sales?</title>
		<link>http://www.tapanray.in/e-detailing-the-future-of-pharmaceutical-sales/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=e-detailing-the-future-of-pharmaceutical-sales</link>
		<comments>http://www.tapanray.in/e-detailing-the-future-of-pharmaceutical-sales/#comments</comments>
		<pubDate>Sun, 29 Sep 2013 23:30:35 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[advantages]]></category>
		<category><![CDATA[askpfizer]]></category>
		<category><![CDATA[Cost]]></category>
		<category><![CDATA[CRM]]></category>
		<category><![CDATA[detailing]]></category>
		<category><![CDATA[digital]]></category>
		<category><![CDATA[doctors]]></category>
		<category><![CDATA[e-detailing]]></category>
		<category><![CDATA[effectiveness]]></category>
		<category><![CDATA[electronic]]></category>
		<category><![CDATA[future]]></category>
		<category><![CDATA[japanese]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[pfizerline]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[physicians]]></category>
		<category><![CDATA[Product]]></category>
		<category><![CDATA[productivity]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Representatives]]></category>
		<category><![CDATA[sales]]></category>
		<category><![CDATA[strategy]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[time]]></category>
		<category><![CDATA[traditional]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=3751</guid>
		<description><![CDATA[Pharmaceutical product detailing to doctors by Medical Representatives (MRs) is believed to fetch the single largest return on marketing investments by the pharmaceutical companies globally, as on date. At the same time, the pharma players, across the world, are increasingly &#8230; <a href="http://www.tapanray.in/e-detailing-the-future-of-pharmaceutical-sales/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/e-detailing-the-future-of-pharmaceutical-sales/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
